151 related articles for article (PubMed ID: 37634315)
1. Clinicopathological significance of androgen receptor expression in extramammary Paget disease: An analysis of 92 patients.
Kuramoto J; Kobayashi K; Hirai I; Nakamura Y; Funakoshi T; Kanai Y
Pathol Res Pract; 2023 Sep; 249():154775. PubMed ID: 37634315
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
3. Expression of structurally unaltered androgen receptor in extramammary Paget's disease.
Fujimoto A; Takata M; Hatta N; Takehara K
Lab Invest; 2000 Sep; 80(9):1465-71. PubMed ID: 11005214
[TBL] [Abstract][Full Text] [Related]
4. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
[TBL] [Abstract][Full Text] [Related]
5. TRPS1 expression in primary and secondary extramammary Paget diseases: An immunohistochemical analysis of 93 cases.
Liu YA; Collins K; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
Hum Pathol; 2024 Jan; 143():5-9. PubMed ID: 38000676
[TBL] [Abstract][Full Text] [Related]
6. Primary invasive extramammary Paget disease on penoscrotum: a clinicopathological analysis of 41 cases.
Shu B; Shen XX; Chen P; Fang XZ; Guo YL; Kong YY
Hum Pathol; 2016 Jan; 47(1):70-7. PubMed ID: 26508372
[TBL] [Abstract][Full Text] [Related]
7. Mammary and Extramammary Paget's Disease Presented Different Expression Pattern of Steroid Hormone Receptors.
Zhou S; Zhong W; Mai R; Zhang G
Biomed Res Int; 2017; 2017():3768247. PubMed ID: 29082243
[TBL] [Abstract][Full Text] [Related]
8. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
[TBL] [Abstract][Full Text] [Related]
9. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.
Diaz de Leon E; Carcangiu ML; Prieto VG; McCue PA; Burchette JL; To G; Norris BA; Kovatich AJ; Sanchez RL; Krigman HR; Gatalica Z
Am J Clin Pathol; 2000 Apr; 113(4):572-5. PubMed ID: 10761460
[TBL] [Abstract][Full Text] [Related]
10. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.
Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Tsutsumida A; Otsuka F; Yamazaki N
Br J Dermatol; 2013 Jun; 168(6):1259-66. PubMed ID: 23360223
[TBL] [Abstract][Full Text] [Related]
11. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
[TBL] [Abstract][Full Text] [Related]
12. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.
Perrotto J; Abbott JJ; Ceilley RI; Ahmed I
Am J Dermatopathol; 2010 Apr; 32(2):137-43. PubMed ID: 20051815
[TBL] [Abstract][Full Text] [Related]
13. A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors.
Ohara K; Fujisawa Y; Yoshino K; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Yoshimura K; Fujimoto M
J Dermatol Sci; 2016 Sep; 83(3):234-9. PubMed ID: 27329007
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.
Zattarin E; Nichetti F; Ligorio F; Mazzeo L; Lobefaro R; Fucà G; Peverelli G; Vingiani A; Bianchi GV; Capri G; de Braud F; Vernieri C
Front Oncol; 2022; 12():925551. PubMed ID: 36059635
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease.
Kawaguchi A; Akiba J; Ogasawara S; Kondo R; Naito Y; Kusano H; Sanada S; Muto I; Nakama T; Yano H
Pathol Res Pract; 2023 Feb; 242():154309. PubMed ID: 36689838
[TBL] [Abstract][Full Text] [Related]
16. Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.
Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Aiba S
Br J Dermatol; 2017 Feb; 176(2):387-394. PubMed ID: 27411503
[TBL] [Abstract][Full Text] [Related]
17. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
18. PD-1 signaling in extramammary paget disease.
Dany M
Cutis; 2020 Jun; 105(6):E46-E48. PubMed ID: 32717007
[TBL] [Abstract][Full Text] [Related]
19. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
